OBJECTIVES: We examined the incidence trends of bladder and kidney cancers using a population-based cancer registration data. METHODS: Age-standardized incidence rates were analyzed using data from the Shanghai Cancer Registry during 1973 to 2005. Annual percentage changes and 95% confidence intervals were calculated to evaluate the incidence changes. Age-period-cohort analysis was further implemented to assess the contributions of age, period and cohort effects to the trends using the intrinsic estimator method. RESULTS: In total, 12,676 bladder and 5,811 kidney cancer patients were registered in urban Shanghai. The age-standardized rates of bladder cancer in males increased from 6.39 to 7.66 per 100,000, or 0.62% per year, whereas the rat...
AimTo investigate trends in bladder cancer incidence, mortality and survival, and cancer-control imp...
Background/Purpose: End-stage renal disease (ESRD) may increase the likelihood of malignancy. The ai...
Background: Kidney cancer is the 7th most common cancer in the UK, accounting for 4% of all new can...
<div><p>Objectives</p><p>We examined the incidence trends of bladder and kidney cancers using a popu...
<p>Trends in incidence rates of cancers of bladder and kidney in urban Shanghai, 1973-2005.</p
Yongli Yang,1 Zhiwei Cheng,2 Xiaocan Jia,1 Nian Shi,3 Zhenhua Xia,1 Weiping Zhang,1 Xuezhong Shi1 1D...
Lack of cancer incidence information for adolescents and young adults led us to describe incidence t...
Objective: Bladder cancer is the twelfth leading cancer and the fifteenth leading cancer-causing dea...
Objectives: To assess contemporary gender, race and stage-specific incidence and trends of bladder c...
Objective: To analyze age-standardized urological cancer incidence rates in Turkey during the last t...
Abstract Background The burden of kidney, bladder, and prostate cancers has changed in recent decade...
<正> Objective To assess the changes in constituents of genitourinary cancer inpatients in Beij...
Background: Kidney cancer is a major urological disease globally, with more than 400 000 new cases d...
Purpose Kidney cancer is one of the fastest rising cancers worldwide. We aimed to examine the trends...
Background. Urothelial cancer (UC) is the leading cancer of patients with end-stage renal disease (E...
AimTo investigate trends in bladder cancer incidence, mortality and survival, and cancer-control imp...
Background/Purpose: End-stage renal disease (ESRD) may increase the likelihood of malignancy. The ai...
Background: Kidney cancer is the 7th most common cancer in the UK, accounting for 4% of all new can...
<div><p>Objectives</p><p>We examined the incidence trends of bladder and kidney cancers using a popu...
<p>Trends in incidence rates of cancers of bladder and kidney in urban Shanghai, 1973-2005.</p
Yongli Yang,1 Zhiwei Cheng,2 Xiaocan Jia,1 Nian Shi,3 Zhenhua Xia,1 Weiping Zhang,1 Xuezhong Shi1 1D...
Lack of cancer incidence information for adolescents and young adults led us to describe incidence t...
Objective: Bladder cancer is the twelfth leading cancer and the fifteenth leading cancer-causing dea...
Objectives: To assess contemporary gender, race and stage-specific incidence and trends of bladder c...
Objective: To analyze age-standardized urological cancer incidence rates in Turkey during the last t...
Abstract Background The burden of kidney, bladder, and prostate cancers has changed in recent decade...
<正> Objective To assess the changes in constituents of genitourinary cancer inpatients in Beij...
Background: Kidney cancer is a major urological disease globally, with more than 400 000 new cases d...
Purpose Kidney cancer is one of the fastest rising cancers worldwide. We aimed to examine the trends...
Background. Urothelial cancer (UC) is the leading cancer of patients with end-stage renal disease (E...
AimTo investigate trends in bladder cancer incidence, mortality and survival, and cancer-control imp...
Background/Purpose: End-stage renal disease (ESRD) may increase the likelihood of malignancy. The ai...
Background: Kidney cancer is the 7th most common cancer in the UK, accounting for 4% of all new can...